Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Oneness Biotech (4743 TT)
Watchlist
19
Analysis
Health Care
•
Taiwan
Oneness Biotech Co Ltd develops botanical new drugs and several biological-active new chemical entities that are purified and molecularly modified from these botanical sources.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Oneness Biotech
•
14 May 2023 23:49
Oneness Biotech (4743 TT): Global Expansion of Marketed Product & Pipeline Progress
Fespixon got approvals for Taiwan and Singapore markets. Bonvadis as a medical device for wound management has been granted market approvals in US,...
Tina Banerjee
Follow
280 Views
Share
bullish
•
Oneness Biotech
•
30 Aug 2022 16:23
Oneness Biotech (4743 TT): Positive Clinical Trial Progress Is Pushing Stock Prices to Higher Highs
Oneness submitted an IND application to the FDA for a phase 1 clinical trial of SNS812 for the treatment of the COVID-19 infection. Fespixon is...
Tina Banerjee
Follow
170 Views
Share
bullish
•
Oneness Biotech
•
19 Mar 2022 18:15
Oneness Biotech (4743 TT): Worth of Attention Ahead of Upcoming Key Milestones
The company’s flagship drug Fespixon has $14 billion global market opportunity, while other late-stage pipeline entail visibility in the long-term....
Tina Banerjee
Follow
339 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.30.3
x